What Indications Have Been Shown to Benefit from Increased Neurosteroids (from etifoxine/GRX-917)?

Neurosteroids could benefit the following neuropsychiatric and neurologic disorders:

• Green (1-11) – preclinical studies using Etifoxine which have demonstrated efficacy
• Blue (12) – Etifoxine is prescribed for depression in France (off-label), and clinical data demonstrates ALLO efficacy
• Purple (13-20) – preclinical and clinical studies suggest increasing biosynthesis of neurosteroids, like ALLO, could benefit these conditions